查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1604619

适体市场：按产品、应用和最终用户划分 - 全球预测 2025-2030

Aptamers Market by Product (Nucleotide Based, Peptide Based), Application (Diagnostics, Research & Development, Therapeutics Development), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年适配体市场价值为13.4亿美元，预计2024年将达到14.8亿美元，年复合成长率为10.91%，预计到2030年将达到27.7亿美元。

适体是短的单链核酸或胜肽，与抗体类似，以高亲和性和特异性结合特定标靶分子。它们采用体外製程合成，可实现快速且经济高效的生产。由于适体的稳定性、低免疫抗原性以及可设计用于多种功能的能力，对适体的需求涵盖多种应用，这使得它们在治疗应用、诊断和生物感测器开发中至关重要。最终用途包括製药、生物技术、环境监测和食品安全等领域，其中适体在疾病治疗、生物标记发现、污染物检测等方面发挥作用。该市场在很大程度上是由分子生物学的进步以及由于其更高的稳定性和更低的生产成本而相对于传统抗体越来越偏爱适配体来推动的。此外，对标靶治疗和个人化医疗的需求不断增加，以及基于适配体的诊断工具的开发，以满足因 COVID-19 大流行而激增的就地检验需求，将进一步刺激增长。适体在药物传递系统中的广泛应用已经成熟，以提高治疗方法的精确度。然而，市场成长受到一些挑战的限制，例如来自现有抗体技术的竞争、适体稳定性和体内递送的技术问题以及监管障碍。创新在于增强适体选择技术、改善体内递送机制、开发基于适体的多功能奈米结构。适配体市场的本质是动态的，其特点是技术快速进步以及生物技术公司和研究机构之间旨在提高适配体功能的合作。公司可以透过策略联盟和研发投资来解决当前的限制并满足诊断和治疗应用的新需求，从而抓住机会。

主要市场统计
基准年[2023] 13.4亿美元
预测年份 [2024] 14.8亿美元
预测年份 [2030] 27.7亿美元
复合年增长率（%） 10.91%

市场动态：揭示快速发展的适体市场的关键市场洞察

供需的动态交互作用正在改变适配体市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 投资药物开发和使用适体进行药物结合亲和性
    • 政府鼓励个人化医疗和治疗的倡议
    • 基于适体的生物感测器和照护现场诊断的不断发展
  • 市场限制因素
    • 对适体半衰期短的担忧
  • 市场机会
    • 适体生产与功能的技术进步
    • 适体在食品安全与真实性检测的新兴应用
  • 市场挑战
    • 开发复杂性和监管限制

波特五力：驾驭适体市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对适体市场的影响

外部宏观环境因素在塑造适配体市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助企业预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解适配体市场竞争状况

适配体市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵适体市场供应商绩效评估

FPNV定位矩阵是评估适配体市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议 规划适配体市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，适体市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 投资药物开发并利用适体实现药物结合亲和性
      • 政府鼓励个人化医疗和治疗的倡议
      • 基于适体的生物感测器和照护现场的开发进展
    • 抑制因素
      • 对适体半衰期短的担忧
    • 机会
      • 适体生产与功能的技术进步
      • 适体在食品安全与真伪检测的应用
    • 任务
      • 开发复杂性和监管限制
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章适体市场：副产品

  • 核苷酸碱基
    • DNA
    • RNA
    • XNA
  • 基于胜肽的

第七章适体市场：依应用分类

  • 诊断
  • 研究与开发
  • 治疗药物开发

第 8 章适体市场：依最终使用者划分

  • 学术和政府研究机构
  • 生物技术和製药公司
  • 合约调查机构

第九章 美洲适体市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区适配体市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲适配体市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Zentek 和 McMaster 宣布 aptamer 平台有正面成果
    • Aptamer Group 与 NeuroBio 合作开发阿兹海默症诊断测试
    • 推出免疫组织化学新试剂解决方案“Optimer-Fc”
    • 新设施开幕以满足对适体和优化器技术不断增长的需求
  • 战略分析和建议

公司名单

  • 2bind GmbH
  • Agilent Technologies, Inc.
  • Aptagen, LLC
  • Aptamer Group
  • Aptamer Sciences, Inc.
  • AptaTargets SL
  • Aptus Biotech SL
  • ATDBio Ltd.
  • Base Pair Biotechnologies, Inc.
  • Basking Biosciences
  • Cage Bio, Inc.
  • Creative Biogene
  • Drive Therapeutics, LLC
  • IVERIC bio, Inc.
  • Kaneka Corporation
  • Maravai LifeSciences
  • Mediomics, LLC
  • NeoVentures Biotechnology, Inc.
  • NOVAPTECH
  • Novartis AG
  • Qualigen, Inc.
  • Raptamer Discovery Group
  • SomaLogic, Inc.
  • TAGCyx Biotechnologies Inc.
  • Vivonics, Inc.
Product Code: MRR-4358BACA838E

The Aptamers Market was valued at USD 1.34 billion in 2023, expected to reach USD 1.48 billion in 2024, and is projected to grow at a CAGR of 10.91%, to USD 2.77 billion by 2030.

Aptamers are short, single-stranded nucleic acids or peptides that bind to specific target molecules with high affinity and specificity, similar to antibodies. They are synthesized through in vitro processes, allowing for rapid and cost-effective production. The necessity of aptamers spans across various applications due to their stability, low immunogenicity, and ability to be engineered for diverse functions, making them pivotal in therapeutic applications, diagnostics, and biosensor development. End-use includes sectors such as pharmaceuticals, biotechnology, environmental monitoring, and food safety, where aptamers play roles in disease treatment, biomarker discovery, and contaminant detection. The market is largely driven by ongoing advancements in molecular biology and a growing preference for aptamers over traditional antibodies due to their increased stability and lower production costs. Also, the rise in demand for targeted therapies and personalized medicine further stimulates growth, along with developments in aptamer-based diagnostic tools responding to the surge in point-of-care testing needs due to the COVID-19 pandemic. Opportunities are ripe in expanding aptamer applications in drug delivery systems, where they enhance the precision of treatment modalities. However, market growth is restrained by challenges such as competition from well-established antibody technologies, technical issues related to the stability and delivery of aptamers in vivo, and regulatory hurdles. Innovation lies in enhancing aptamer selection technologies, improving in vivo delivery mechanisms, and developing multifunctional aptamer-based nanostructures. The nature of the aptamer market is dynamic, characterized by rapid technological advancements and partnerships between biotech firms and research institutions aiming to improve aptamer functionalities. Businesses can capitalize on opportunities through strategic collaborations and investing in R&D to address current limitations and meet emerging demands in diagnostics and therapeutic applications.

KEY MARKET STATISTICS
Base Year [2023] USD 1.34 billion
Estimated Year [2024] USD 1.48 billion
Forecast Year [2030] USD 2.77 billion
CAGR (%) 10.91%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Aptamers Market

The Aptamers Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Investments in drug development and use of aptamers for drug-binding affinity
    • Government initiatives encouraging personalized medicine and treatment
    • Rising development of aptamer-based biosensors and point-of-care diagnostics
  • Market Restraints
    • Concerns associated with short half-life of aptamers
  • Market Opportunities
    • Technological advancements in aptamer production and functionalities
    • Emergence use of aptamers for food safety and authenticity testing
  • Market Challenges
    • Development complexity and regulatory limitations

Porter's Five Forces: A Strategic Tool for Navigating the Aptamers Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Aptamers Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Aptamers Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Aptamers Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Aptamers Market

A detailed market share analysis in the Aptamers Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Aptamers Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Aptamers Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Aptamers Market

A strategic analysis of the Aptamers Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Aptamers Market, highlighting leading vendors and their innovative profiles. These include 2bind GmbH, Agilent Technologies, Inc., Aptagen, LLC, Aptamer Group, Aptamer Sciences, Inc., AptaTargets SL, Aptus Biotech S.L., ATDBio Ltd., Base Pair Biotechnologies, Inc., Basking Biosciences, Cage Bio, Inc., Creative Biogene, Drive Therapeutics, LLC, IVERIC bio, Inc., Kaneka Corporation, Maravai LifeSciences, Mediomics, LLC, NeoVentures Biotechnology, Inc., NOVAPTECH, Novartis AG, Qualigen, Inc., Raptamer Discovery Group, SomaLogic, Inc., TAGCyx Biotechnologies Inc., and Vivonics, Inc..

Market Segmentation & Coverage

This research report categorizes the Aptamers Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Nucleotide Based and Peptide Based. The Nucleotide Based is further studied across DNA, RNA, and XNA.
  • Based on Application, market is studied across Diagnostics, Research & Development, and Therapeutics Development.
  • Based on End-User, market is studied across Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies, and Contract Research Organizations.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Investments in drug development and use of aptamers for drug-binding affinity
      • 5.1.1.2. Government initiatives encouraging personalized medicine and treatment
      • 5.1.1.3. Rising development of aptamer-based biosensors and point-of-care diagnostics
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns associated with short half-life of aptamers
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in aptamer production and functionalities
      • 5.1.3.2. Emergence use of aptamers for food safety and authenticity testing
    • 5.1.4. Challenges
      • 5.1.4.1. Development complexity and regulatory limitations
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Aptamers Market, by Product

  • 6.1. Introduction
  • 6.2. Nucleotide Based
    • 6.2.1. DNA
    • 6.2.2. RNA
    • 6.2.3. XNA
  • 6.3. Peptide Based

7. Aptamers Market, by Application

  • 7.1. Introduction
  • 7.2. Diagnostics
  • 7.3. Research & Development
  • 7.4. Therapeutics Development

8. Aptamers Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic & Government Research Institutes
  • 8.3. Biotechnology & Pharmaceutical Companies
  • 8.4. Contract Research Organizations

9. Americas Aptamers Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Aptamers Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Aptamers Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Zentek and McMaster Announce Positive Results for the Aptamer Platform
    • 12.3.2. Aptamer Group and Neuro-Bio Collaborate to Develop Alzheimer's Disease Diagnostic Test
    • 12.3.3. Launch of Optimer-Fc as a New Reagent Solution for Immunohistochemistry
    • 12.3.4. Aptamer Opens New Facilities to Meet Growing Demand for Optimer Technology
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 2bind GmbH
  • 2. Agilent Technologies, Inc.
  • 3. Aptagen, LLC
  • 4. Aptamer Group
  • 5. Aptamer Sciences, Inc.
  • 6. AptaTargets SL
  • 7. Aptus Biotech S.L.
  • 8. ATDBio Ltd.
  • 9. Base Pair Biotechnologies, Inc.
  • 10. Basking Biosciences
  • 11. Cage Bio, Inc.
  • 12. Creative Biogene
  • 13. Drive Therapeutics, LLC
  • 14. IVERIC bio, Inc.
  • 15. Kaneka Corporation
  • 16. Maravai LifeSciences
  • 17. Mediomics, LLC
  • 18. NeoVentures Biotechnology, Inc.
  • 19. NOVAPTECH
  • 20. Novartis AG
  • 21. Qualigen, Inc.
  • 22. Raptamer Discovery Group
  • 23. SomaLogic, Inc.
  • 24. TAGCyx Biotechnologies Inc.
  • 25. Vivonics, Inc.

LIST OF FIGURES

  • FIGURE 1. APTAMERS MARKET RESEARCH PROCESS
  • FIGURE 2. APTAMERS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL APTAMERS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL APTAMERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL APTAMERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL APTAMERS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL APTAMERS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL APTAMERS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL APTAMERS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL APTAMERS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL APTAMERS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS APTAMERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS APTAMERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES APTAMERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES APTAMERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC APTAMERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC APTAMERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. APTAMERS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. APTAMERS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. APTAMERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL APTAMERS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL APTAMERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL APTAMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. APTAMERS MARKET DYNAMICS
  • TABLE 7. GLOBAL APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL APTAMERS MARKET SIZE, BY DNA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL APTAMERS MARKET SIZE, BY RNA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL APTAMERS MARKET SIZE, BY XNA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL APTAMERS MARKET SIZE, BY PEPTIDE BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL APTAMERS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL APTAMERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL APTAMERS MARKET SIZE, BY THERAPEUTICS DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL APTAMERS MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL APTAMERS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL APTAMERS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS APTAMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES APTAMERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC APTAMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. APTAMERS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 191. APTAMERS MARKET, FPNV POSITIONING MATRIX, 2023